Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10180 |
| Vaccine Name | iNCOVACC |
| Disease Name | COVID-19 |
| Disease Classification | Respiratory |
| Virus Name | SARS-CoV-2 virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Non-replicating viral vector |
| Vaccine Status | Phase 1 |
| Manufacturer | Bharat Biotech International Limited |
| Year of Manufacturing | 2021 |
| Manufacturing Country | India |
| Age | 18 - 60 years |
| Dosage | 2 doses 28 days apart |
| Administration Route | Intranasal |
| Adjuvant | NA |
| Target Strain | Spike protein of SARS-CoV-2 virus |
| Description | NA |
| Approving Organisation | NA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | BBV154 |
| PMID | NA |
| Clinical Trial ID | NA |
| Reference Link | http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51327 |
| Additional Links | NA |